NASHNEXT
LIVE

Serial Number

99928816

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Jul 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NASHNEXT Trademark

Serial Number: 99928816

NASHNEXT is a trademark filed by GENFIT on July 8, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

GENFIT (46 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

July 8, 2026

Registration Date

Not Registered

Goods & Services

Downloadable computer software platforms for for purchasing medical diagnostic tests, accessing laboratory test results, managing personal health information, communicating healthcare-related information between healthcare professionals and patients and supporting physician-directed identification of patients at risk; Downloadable clinical decision support software; Downloadable software for risk assessment and patient stratification

Providing medical information, consultancy and advisory services; Medical evaluation services for identifying patients at risk for metabolic disorders, liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Medical screening services for identifying patients at risk of MASH and liver fibrosis; Patient risk stratification services; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical information and medical consultancy and advisory services in the nature of clinical interpretation of biomarkers and assessment of the risk of liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns

Filing History

NEW APPLICATION ENTERED
Jul 8, 2026 NWAP
APPLICATION FILING RECEIPT MAILED
Jul 8, 2026 MAFR